Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus (T2D) and Chronic Kidney Disease (CKD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06330194
What this trial is testing

Next Generation Advanced Insulin Delivery System in Adults With Diabetes and Advanced Renal Disease

Who this might be right for
DialysisChronic Kidney DiseaseDiabetes Mellitus, Type 2+3 more
Steno Diabetes Center Copenhagen 15
Not applicableStudy completedNCT06833541
What this trial is testing

Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease

Who this might be right for
Diabetic Nephropathy Type 2Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine 556
Not applicableStudy completedNCT04931030
What this trial is testing

Low Carbohydrate Diet in Diabetic Kidney Disease

Who this might be right for
Type 2 Diabetes MellitusDiabetic Kidney DiseaseObesity
Universiti Teknologi Mara 30
Not applicableLooking for participantsNCT06278207
What this trial is testing

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Bayer 50,000
Testing effectiveness (Phase 2)Study completedNCT02316821
What this trial is testing

The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Kyowa Kirin Co., Ltd. 216
Post-approval studies (Phase 4)Looking for participantsNCT06727409
What this trial is testing

Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i as Triple Therapy With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Patients With Type 2 Diabetes
Chinese University of Hong Kong 82
Post-approval studies (Phase 4)Active Not RecruitingNCT00725127
What this trial is testing

Chronotherapy with Low-dose Aspirin for Primary Prevention

Who this might be right for
Type 2 Diabetes
University of Vigo 3,200
Not applicableUnknownNCT01731080
What this trial is testing

Arterial Wall Calcium Load in Pseudoxanthoma Elasticum

Who this might be right for
Pseudoxanthoma ElasticumType 2 DiabetesChronic Kidney Disease
University Hospital, Angers 60
Not applicableLooking for participantsNCT04916132
What this trial is testing

Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors

Who this might be right for
Chronic Kidney DiseasesAlbuminuriaDiabetic Kidney Disease+4 more
Herlev Hospital 300
Early research (Phase 1)Looking for participantsNCT07024823
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort

Who this might be right for
Chronic Kidney Disease
AstraZeneca 124
Not applicableLooking for participantsNCT05692388
What this trial is testing

Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Who this might be right for
Diabetic Nephropathy Type 2 - UncontrolledDiabetes Mellitus, Type 2Chronic Kidney Diseases
Medical College of Wisconsin 330
Early research (Phase 1)Ended earlyNCT02008851
What this trial is testing

A Phase 1, Open-label Safety Study of NKA in Patients With Type 2 Diabetes

Who this might be right for
Chronic Kidney Disease
Tengion 1
Testing effectiveness (Phase 2)Study completedNCT05018416
What this trial is testing

Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)

Who this might be right for
Chronic Kidney DiseasesType 1 Diabetes MellitusType 2 Diabetes Mellitus
Prokidney 53
Testing effectiveness (Phase 2)Study completedNCT01807221
What this trial is testing

Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chronic Kidney Disease Alone

Who this might be right for
Heart Failure
Bayer 1,066
Post-approval studies (Phase 4)Looking for participantsNCT07026539
What this trial is testing

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease Due to Type 2 Diabetes MellitusCardiovascular Diseases
University of Aarhus 80
Large-scale testing (Phase 3)Study completedNCT01986855
What this trial is testing

The Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 468
Not applicableStudy completedNCT05465317
What this trial is testing

Evaluating Comparative Effectiveness of Empagliflozin in Type 2 Diabetes Population With and Without Chronic Kidney Disease

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 62,197
Not applicableStudy completedNCT03157960
What this trial is testing

Effect of Acute Fructose Load in Human

Who this might be right for
Chronic Kidney DiseasesDiabetes Mellitus, Type 2
Karolinska University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02358096
What this trial is testing

Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Astellas Pharma Europe B.V. 125
Not applicableStudy completedNCT03921242
What this trial is testing

Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease

Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency, Chronic
Weill Medical College of Cornell University 4,888
Next Page